210 related articles for article (PubMed ID: 27400136)
1. Choroidal Watershed Zone and Growth of Polypoidal Choroidal Vasculopathy.
Shin MK; Lee JE; Byon IS; Park SW
Curr Eye Res; 2017 Feb; 42(2):252-259. PubMed ID: 27400136
[TBL] [Abstract][Full Text] [Related]
2. Topographical relationship between the choroidal watershed zone and submacular idiopathic choroidal neovascularisation.
Lee JE; Shin MK; Chung IY; Lee JE; Kim HW; Lee SJ; Park SW; Byon IS
Br J Ophthalmol; 2016 May; 100(5):652-9. PubMed ID: 26324512
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Optical Coherence Tomography Angiography.
Tomiyasu T; Nozaki M; Yoshida M; Ogura Y
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT324-30. PubMed ID: 27409489
[TBL] [Abstract][Full Text] [Related]
4. A Comparison Study of Polypoidal Choroidal Vasculopathy Imaged with Indocyanine Green Angiography and Swept-Source Optical Coherence Tomography Angiography.
Kim K; Yang J; Feuer W; Gregori G; Kim ES; Rosenfeld PJ; Yu SY
Am J Ophthalmol; 2020 Sep; 217():240-251. PubMed ID: 32445699
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Polypoidal Choroidal Vasculopathy With Optical Coherence Tomography Angiography.
Wang M; Zhou Y; Gao SS; Liu W; Huang Y; Huang D; Jia Y
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT526-32. PubMed ID: 27472276
[TBL] [Abstract][Full Text] [Related]
6. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
Baek J; Lee JH; Jung BJ; Kook L; Lee WK
Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
[TBL] [Abstract][Full Text] [Related]
7. Choroidal Vascular Abnormalities by Ultra-widefield Indocyanine Green Angiography in Polypoidal Choroidal Vasculopathy.
Jeong A; Lim J; Sagong M
Invest Ophthalmol Vis Sci; 2021 Feb; 62(2):29. PubMed ID: 33605985
[TBL] [Abstract][Full Text] [Related]
8. DETAILED CHARACTERIZATION OF CHOROIDAL MORPHOLOGIC AND VASCULAR FEATURES IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Gupta P; Ting DSW; Thakku SG; Wong TY; Cheng CY; Wong E; Mathur R; Wong D; Yeo I; Gemmy Cheung CM
Retina; 2017 Dec; 37(12):2269-2280. PubMed ID: 28145972
[TBL] [Abstract][Full Text] [Related]
9. Fundus autofluorescence in polypoidal choroidal vasculopathy.
Yamagishi T; Koizumi H; Yamazaki T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1650-7. PubMed ID: 22512987
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.
Kawamura A; Yuzawa M; Mori R; Haruyama M; Tanaka K
Acta Ophthalmol; 2013 Sep; 91(6):e474-81. PubMed ID: 23848133
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study.
Lee JE; Shin JP; Kim HW; Chang W; Kim YC; Lee SJ; Chung IY; Lee JE;
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):493-502. PubMed ID: 27628062
[TBL] [Abstract][Full Text] [Related]
12. One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
Matsumiya W; Honda S; Otsuka K; Miki A; Nagai T; Imai H; Kusuhara S; Nakamura M
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):541-548. PubMed ID: 27687988
[TBL] [Abstract][Full Text] [Related]
13. Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes.
Hwang HJ; Kim JH; Chang YS; Kim JW; Kim CG
Korean J Ophthalmol; 2017 Jun; 31(3):230-239. PubMed ID: 28534339
[TBL] [Abstract][Full Text] [Related]
14. Comparison of subfoveal choroidal structures in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
Takahashi Y; Koizumi H; Hasegawa T; Izumi T; Maruko I; Sonoda S; Sakamoto T; Iida T
Jpn J Ophthalmol; 2018 Sep; 62(5):576-583. PubMed ID: 30069649
[TBL] [Abstract][Full Text] [Related]
15. Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration.
Lorentzen TD; Subhi Y; Sørensen TL
Acta Ophthalmol; 2018 Aug; 96(5):475-480. PubMed ID: 29193780
[TBL] [Abstract][Full Text] [Related]
16. Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy.
Gemmy Cheung CM; Yeo I; Li X; Mathur R; Lee SY; Chan CM; Wong D; Wong TY
Am J Ophthalmol; 2013 Feb; 155(2):295-304.e1. PubMed ID: 23111181
[TBL] [Abstract][Full Text] [Related]
17. Novel Findings of Polypoidal Choroidal Vasculopathy via Optical Coherence Tomography Angiography.
Seong S; Choo HG; Kim YJ; Kim JY; Lee JH; Oh HS; You YS; Kim SH; Kwon OW
Korean J Ophthalmol; 2019 Feb; 33(1):54-62. PubMed ID: 30746912
[TBL] [Abstract][Full Text] [Related]
18. Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography.
Kang SW; Chung SE; Shin WJ; Lee JH
Br J Ophthalmol; 2009 Jun; 93(6):759-64. PubMed ID: 19304584
[TBL] [Abstract][Full Text] [Related]
19. Punctate hyperfluorescent spots associated with polypoidal choroidal vasculopathy on indocyanine green angiography.
Kim H; Lee JH; Kwon KY; Byeon SH; Lee SC; Lee CS
Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):423-7. PubMed ID: 25970862
[TBL] [Abstract][Full Text] [Related]
20. Characteristic appearances of fundus autofluorescence in treatment-naive and active polypoidal choroidal vasculopathy: a retrospective study of 170 patients.
Zhao X; Xia S; Chen Y
Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1101-1110. PubMed ID: 29656364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
